Kursprognose für Acurx Pharmaceuticals Inc (ACXP)ACXPAcurx Pharmaceuticals Inc

Alphio's ACXP stock price prediction model matches the current Acurx Pharmaceuticals Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.08 (+0.96%). The 1-week path is $1.07 (+0.18%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Acurx Pharmaceuticals Inc (ACXP) is a good buy right now due to its recent positive developments, including a conditional FDA acceptance for its antibiotic candidate CIFBEZY and an improved cash position of $10.7 million, which supports operational funding for at least one year. The stock is currently priced at $1.065, significantly below its 52-week high of $7.54, indicating a potential for recovery. However, investors should be cautious of the company's ongoing net losses, which amounted to $2.3 million in Q2 2026, as this represents a risk to profitability.

Acurx Pharmaceuticals Inc (ACXP) last closed at $1.0650001, gaining +12.62%. These facts feed the 1-day and 1-week ACXP price prediction above.